Open Access

Association between genetic polymorphisms and carotid atherosclerosis in patients treated with radiotherapy for nasopharyngeal carcinoma

  • Chuang Yuan1, 3,
  • Shea Ping Yip1,
  • Vincent WC Wu1,
  • Dora LW Kwong2,
  • Isabella WY Cheuk1 and
  • Michael Ying1Email author
Radiation Oncology201510:39

https://doi.org/10.1186/s13014-015-0341-8

Received: 11 October 2014

Accepted: 28 January 2015

Published: 13 February 2015

Abstract

Background

Radiotherapy (RT) of the neck is commonly given to nasopharyngeal carcinoma (NPC) patients for preventing cervical lymph node metastasis. However, neck RT may induce the development of carotid atherosclerosis. The mechanisms of radiation-induced carotid atherosclerosis are still unclear and no previous study has investigated the genetic involvement of radiation-induced carotid atherosclerosis. The present study aims to determine the association between genetic polymorphisms and carotid atherosclerosis in patients treated with RT for nasopharyngeal carcinoma.

Methods

The present study recruited 128 post-RT NPC patients. Carotid plaque score was assessed using ultrasonography. Thirteen single nucleotide polymorphisms (SNPs) that affect the function of anti-atherosclerotic genes, including SOD2, SOD3, CAT, PON1, PPARG, ADIPOQ, IL10, TGFB1 and NOS3, were genotyped. Association between the 13 SNPs and carotid atherosclerosis was evaluated using multiple regression after adjustment for covariates (PLINK). Multiple testing was corrected using Benjamini-Hochberg step-up false discovery rate controlling procedure.

Results

rs662 and rs705379 of PON1 were close to be significantly associated with carotid plaque score (Corrected P value, P cor  = 0.0528 and P cor  = 0.0842). When the two SNPs were combined together, TC haplotype in rs662-rs705379 of PON1 was significantly associated with higher carotid plaque score (P cor  < 0.05). None of the other SNPs showed significant association with carotid plaque score.

Conclusions

TC haplotype in rs662-rs705379 of PON1 is likely to be a genetic risk factor of carotid plaque score. Post-RT NPC patients with the TC haplotype may need earlier and more frequent carotid ultrasound examinations for early detection of carotid atherosclerosis.

Keywords

Radiation Nasopharyngeal carcinoma Carotid atherosclerosis Carotid plaque score Single nucleotide polymorphisms Paraoxonase

Background

Nasopharyngeal carcinoma (NPC) is a common head and neck malignancy in Southeast Asia and Southern China [1]. Radiotherapy (RT) is the standard strategy for treating nasopharyngeal carcinoma (NPC). Owing to the high prevalence of cervical lymph node metastasis in NPC patients, RT of the neck is usually given to the patients for preventing or treating the nodal metastasis [2]. However, ionizing radiation in neck RT damages the carotid artery and may induce carotid atherosclerosis, which may lead to cerebrovascular events [3-6].

The mechanisms of radiation-induced carotid atherosclerosis are still unknown. However, the mechanisms of spontaneous atherosclerosis are well established, which provide baseline information for the understanding of the mechanisms of radiation-induced carotid atherosclerosis. Different pathways in the regulation of oxidative stress, lipid metabolisms, and inflammation may protect the carotid artery from atherosclerosis. There are many genes whose encoded proteins are involved in these protective pathways. Superoxide dismutases (SODs) are the primary enzymes in the defense of oxidative stress, which convert the toxic superoxide anions to the less toxic hydrogen peroxide (H2O2) [7]. Catalase (CAT) further scavenges the toxic H2O2 by converting it into water (H2O) and molecular oxygen (O2) [8]. Paraoxonase 1 (PON1) prevents the oxidation of low intensity lipoprotein (LDL), and inhibits the uptake of oxidized LDL by and cholesterol synthesis in macrophages [9]. Peroxisome proliferators-activated receptor γ (PPARG) is a pivotal nuclear receptor that regulates the expression of genes involved in lipid metabolisms and inflammatory responses [10]. Adiponectin (ADIPOQ) suppresses the inflammatory responses and the uptake of oxLDL by macrophages [11]. Interleukin-10 (IL10) and transforming growth factor-β1 (TGFB1) are the most important anti-inflammatory cytokines in immune cells [12,13]. Endothelial nitric oxide synthase (NOS3) catalyzes the production of nitric oxide, which prevents platelet aggregation, adhesion molecule expression in endothelial cells and vascular SMC proliferation [14].

Some single nucleotide polymorphisms (SNPs) that affect the expression of these genes (SOD2, SOD3, CAT, PON1, PPARG, ADIPOQ, IL10, TGFB1 and NOS3) and/or the functions of their corresponding proteins have been shown to be associated with spontaneous atherosclerosis [15-24]. However, the association of these SNPs with radiation-induced carotid atherosclerosis is still unknown. Therefore, the present study was undertaken to investigate the association between the SNPs in these nine genes and the severity of carotid atherosclerosis in post-RT NPC patients. The findings will offer potential genetic markers of radiation-induced carotid atherosclerosis, which might facilitate the selection of high-risk patients with carotid atherosclerosis so that timely diagnosis and treatment can be given to the patients.

Methods

Subjects

Post-RT NPC patients were recruited from the Department of Clinical Oncology of Queen Mary Hospital from March 2013 to March 2014. The inclusion criteria of subjects were local residents, Han Chinese NPC patients, older than 18 years, and completed RT for at least four years, whilst the exclusion criteria of subjects were more than one course of RT, history of carotid atherosclerosis prior to RT, previous carotid endarterectomy and carotid stenting.

This study was approved by the Human Subject Ethics Subcommittee of the Hong Kong Polytechnic University and the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster. Written consent was obtained from all patients before the commencement of the interview and ultrasound examination.

Clinical information

Archived clinical records were reviewed and individual face-to-face interviews were conducted. The information of post-RT duration, radiation dose, chemotherapy and history of carotid atherosclerosis was obtained from archived clinical records. The presence of cardiovascular risk factors was identified as follows: 1) DM, diagnosed with DM in the clinical record, taking medications to lower blood glucose and/or fasting plasma (blood) glucose ≥ 7.0 (6.1) mmol/L [25]; 2) hypertension, diagnosed with hypertension in the clinical record, undergoing anti-hypertensive medications and/or the measured blood pressure ≥ 140/90 mmHg [26]; 3) hypercholesterolemia, diagnosed with hypercholesterolemia in the clinical record, undergoing medications to lower the cholesterol level and/or fasting total cholesterol ≥ 5.2 mmol/L [27]; 4) CHD, diagnosed with coronary vascular disease in the clinical record and/or had coronary stenting [28]; 5) smoking, current smoker consuming 10 cigarettes per day for at least six months [28].

Selecting and genotyping of SNPs

A literature research was performed for the selection of candidate genes and relevant SNPs in the present study (Pubmed). Candidate genes involving oxidative stress, lipid metabolism and inflammation and having association with atherosclerosis were reviewed. Only the genes, in which SNPs influence the expression of these genes or the function of the encoded proteins, and have minor allele frequency > 0.1 in Han Chinese and evidences for association with spontaneous atherosclerosis, including carotid atherosclerosis, coronary atherosclerosis, and ischemic cardiovascular and cerebrovascular diseases, were selected. In total, 13 SNPs in the 9 genes, SOD2, SOD3, CAT, PON1, PPARG, ADIPOQ, IL10, TGFB1 and NOS3, were included in the present study (Table 1) [15-24]. Genomic DNA was extracted from 6 ml of peripheral blood for genotyping. Restriction fragment length polymorphism (RFLP) and unlabeled probe melting analysis (UPMA) were used for genotyping as described previously [29-31]. The primers and probes used in genotyping are shown in Table 1.
Table 1

Primers and probes in genotyping

Genes

SNPs

Forward primers

Reward primers

Probes

Genotyping methods

SOD2

rs4880

CCA GCC TGC GTA GAC GGT

CGT GGT GCT TGC TGT GGT G

AGC CCA GAT ACC CCA AAG CCG GAG CCA Gaa

UPMA

SOD3

rs2536512

AGG ACT CAG CGG AGC CCA ACT

18 T + TTG GCA CGG GAC GCA AGC TG

-

RFLP (BstUI)

CAT

rs769217

TGT TAC CGC CCC TAG TCA GTG TC

CAC CTC GGG AGC ACC TTT ACC A

-

RFLP (BstXI)

PON1

rs662

10 T + GAA TGA TAT TGT TGC TGT GGG ACC TGA G

CCA TCG GGT GAA CTG TTG ATT CCA TTA G

-

RFLP (MboI)

rs705379

AAA TGG GAC TTT TGG CTG A

ACA CTG ACG GGC TAG GA

CGC CGA TTT GCC CGC CCC GCC CCT CCC Caa ta

UPMA

PPARG

rs3856806

GCT GAA CCA TCC TGA GTC CTC

33 T + TGG AAG AAG GGA CAT GTT GGC

-

RFLP (NspI)

ADIPOQ

rs1501299

CAC CGA CAG AGC CTT GCA CAT TAG

GGG GGT CTG CAC AGG TTG GAT G

-

RFLP (BsmI)

rs2241766

15 T + GAT GCT GTT GCT GGG AGC TGT

30 T + CCC GAG A CGC CAT CCA ACC TGT GC

-

RFLP (AvaI)

IL10

rs1800872

GGA GCC TGG AAC ACA TCC TG

AAA TGA GGG GGT GGG CTA AAT ATC

ACC CCC CCT GTC CTG TAG GAA GCC AGt CTa ata

UPMA

TGFB1

rs1800469

TGA CCC CAG CTA AGG CAT G

TTT TTC CTC TTC TCC CGA CCA G

-

RFLP (Eco81I)

rs1800470

TCA CCA GCT CCA TGT CGA TA

ATC CCT GTT CGC GCT CTC

CAG CAG CGG TAG CAG CAG CGG CAG CAG Caa

UPMA

rs4803455

TCA CTG CAA CCT CTG TGT CTT

20 T + CTG CAT ATT TGA CAC CCT GTA TT

-

RFLP (TasI)

NOS3

rs1799983

ACC CCA GAA AAC GGT CGC TTC G

CCC CGA TTT CCA GCA GCA TGT TG

-

RFLP (MboI)

UPMA, unlabeled probe melting analysis; RFLP, restriction fragment length polymorphism.

Ultrasound examinations

Carotid ultrasound examinations were performed in a 22°C air-conditioned examination room using the Esaote MyLab Twice ultrasound unit in conjunction with a 4–13 MHz linear transducer (Esaote, Genoa, Italy). Subjects lied supine on the examination couch with the neck slightly extended and the head turned away from the side under examination. Using gray-scale ultrasound, the extra-cranial carotid artery was screened longitudinally and transversely. Carotid plaque was identified as a focal thickening >50% of the adjacent intima-media layer [32]. Once a carotid plaque was identified, transverse gray-scale images of the plaque were obtained and the degree of carotid stenosis was expressed as a percentage reduction of the lumen diameter at the most stenotic site. Carotid plaque score was evaluated using an adjusted plaque scoring system [28]. In the scoring system, the carotid artery was divided into five segments: 1. Proximal common carotid artery (≥2 cm proximal to carotid bifurcation); 2. Distal common carotid artery (<2 cm proximal to carotid bifurcation); 3. Carotid bulb and bifurcation; 4. Internal carotid artery; and 5. External carotid artery. The degree of carotid stenosis in each segment was measured and carotid plaque score was expressed as the summation of the degree of carotid stenosis of all segments in both carotid arteries (Figure 1).
Figure 1

Assessment of carotid plaque score. A). Five segments of the extra-cranial carotid artery: 1. proximal common carotid artery (≥2 cm proximal to carotid bifurcation); 2. distal common carotid artery (<2 cm proximal to carotid bifurcation); 3. carotid bulb and bifurcation; 4. internal carotid artery; and 5. external carotid artery. B). A longitudinal gray-scale image of a carotid plaque in the distal common carotid artery. C). A transverse gray-scale ultrasound image of the carotid plaque in B. The degree of the carotid stenosis is expressed as the percentage reduction of lumen diameter (1-D1/D2 = 41.3%). Carotid plaque score is the summation of the degree of carotid stenosis of the five segments in both carotid arteries.

Statistical analysis

Data of carotid plaque score was transformed logarithmically because it was not normally distributed. Testing of genotypes for Hardy-Weinberg equilibrium (HWE) in all subjects was determined by exact test as executed in PLINK (version 1.07, [33]). The threshold for significant deviation from HWE was set as 0.01 [34]. Only markers fulfilling HWE were included in association analyses.

In the potential covariates, such as age, gender, radiation dose, chemotherapy, post-RT duration and cardiovascular risk factors, the significant predictors in regression models were adjusted in association analyses. Linear regression executed in PLINK was used for assessing the association between single SNP and carotid plaque score with adjustment for post-RT duration and number of cardiovascular risk factors (significant predictors in regression models). The regression analysis was performed under additive, dominant or recessive models. FDR correction was used for correcting multiple testing. P cor  < 0.05 was considered as significant for association analysis.

Three genes, PON1, ADIPOQ and TGFB1, had more than one SNP examined in the present study. The haplotypes in each of these three genes were determined for the association with carotid plaque score in post-RT NPC patients. Sliding window (2 or 3 SNPs per window) using linear regression in PLINK was utilized for the association analysis with adjustment for post-RT duration and number of cardiovascular risk factors. FDR correction was also used for correcting multiple testing. Linkage disequilibrium (LD) statistics D’ and r2 in paired SNPs were calculated using Pairwise LD in PLINK. P cor  < 0.05 was considered as significant for association analysis.

Results

Demographic information

A total of 128 post-RT NPC patients were included in the present study. All patients were treated conventional 2D RT of the neck. The mean age of the patients was 55.2 ± 8.8 years with a range of 33 to 86 years. There were 86 males and 42 females. The mean radiation dose was 66.82 ± 3.20 Gy with a range of 58.44 to 73.72 Gy. Of the 128 patients, 63 were also treated with chemotherapy. The mean post-RT duration was 12.8 ± 6.0 years with a range of 4 to 37 years. The most common cardiovascular risk factor was hypercholesterolemia (n = 39), followed by hypertension (n = 35) and then by DM (n = 14). Only 5 patients were current smoker, and 5 patients had CHD and 7 patients developed stroke or transient ischemia attack (Table 2).
Table 2

Demographic information of post-RT NPC patients

Parameters

Total n = 128

Age, years

55.2 ± 8.8

Gender (female/male), n

42/86

Chemotherapy, n (%)

63 (49.2%)

Radiation dose, Gy

66.82 ± 3.20

Post-RT duration, years

12.6 ± 6.0

Hypercholesterolemia, n (%)

39 (30.5%)

Hypertension, n (%)

35 (27.3%)

Diabetes mellitus, n (%)

14 (10.9%)

Current smoker, n (%)

5 (3.9%)

Coronary heart disease, n (%)

5 (3.9%)

Stroke or transient ischemia attack, n (%)

7 (5.5%)

Presence of carotid plaque, n (%)

114 (89.1%)

Carotid plaque score

1.41 ± 1.37

Association analysis

Genotype proportions were all in HWE for 13 SNPs (P > 0.01, Table 3). In the 13 SNPs, only rs662 and rs705379 in PON1 were close to be significantly associated with carotid plaque score in post-RT NPC patients (rs662, P cor  = 0.0842 in additive model and P cor =0.0528 in dominant model; and rs705379, P cor  = 0.0842 in additive and dominant models, Table 3). T allele of rs662 and C allele of rs705379 were the risk alleles for higher carotid plaque score (rs662, TT + TC vs CC: 1.76 ± 1.60 vs 1.07 ± 0.97; rs705379, TT + TC vs CC: 1.22 ± 1.01 vs 1.79 ± 1.82). When the two SNPs were combined, the haplotype window rs662-rs705379 in PON1 had a significant association with carotid plaque score (P cor  < 0.05, Table 4). TC haplotype of rs662-rs705379 posed a higher risk for higher carotid plaque score (unstandardized coefficients = 0.0873, P cor  < 0.05). None of other SNPs and haplotypes showed significant association with carotid plaque score (P cor  > 0.05, Tables 3 and 4).
Table 3

Genotypes, minor allele frequency, Hardy-Weinberg Equilibrium and single-marker association analysis in all selected SNPs

Genes

SNPs

Alleles a (1/2)

Genotypes (11/12/22)

MAF

HWE

Corrected P values b

1-β

SS 0.8

Additive

Dominant

Recessive

SOD2

rs4880

G/A

4/24/100

0.1250

0.1065

0.9588

0.9588

0.9588

0.0230

1371

SOD3

rs2536512

A/G

10/60/58

0.3125

0.4103

0.9588

0.9609

0.9588

0.0030

7785

CAT

rs769217

T/C

29/69/30

0.4961

0.4792

0.9588

0.9657

0.9588

0.0040

5862

PON1

rs662

T/C

15/49/64

0.3086

0.2986

0.0842

0.0528

0.9588

0.5240

194

 

rs705379

T/C

35/49/44

0.4648

0.0124

0.0842

0.0842

0.4988

0.3020

283

PPARG

rs3856806

T/C

8/43/77

0.2305

0.6168

0.9588

0.9588

0.9588

0.0130

2072

ADIPOQ

rs1501299

T/G

8/56/64

0.2812

0.5107

0.9657

0.9588

0.9588

0.0030

8510

 

rs2241766

G/T

9/59/60

0.3008

0.3994

0.9657

0.9657

0.9588

0.0050

5443

IL10

rs1800872

G/T

17/47/64

0.3164

0.1012

0.8279

0.9588

0.5357

0.0660

684

TGFB1

rs1800469

G/A

20/61/47

0.3945

1

0.9588

0.9588

0.9588

0.0100

2632

 

rs1800470

A/G

21/61/46

0.4023

1

0.9588

0.9588

0.9588

0.0220

1404

 

rs4803455

A/C

20/50/58

0.3516

0.1203

0.9588

0.9588

0.9588

0.0080

3085

NOS3

rs1799983

T/G

1/29/98

0.1211

0.6926

0.9657

0.9813

0.9588

0.0040

5862

aAllele 1 is the minor allele and allele 2 is the major allele.

bCorrected P values after false discovery rate correction for multiple testing (including the 39 tests in the single-marker association analyses between the 13 SNPs and carotid plaque score across the three genetic models).

Post-RT duration and number of cardiovascular risk factors were adjusted using linear regression in all association analyses. Statistical power (1-β) was calculated using the model with smallest observed P value. SS0.8 was the sample size to achieve a statistical power of 0.8 in the corresponding analysis. MAF, minor allele frequency; HWE, Hardy-Weinberg Equilibrium.

Table 4

Association analyses between haplotypes and carotid plaque score in post-RT NPC patients

Genes

D’

r 2

Hap

Freq

P cor

1-β

SS 0.8

PON1

       

rs662-rs705379

0.871

0.294

TC

0.290

0.0158

0.849

117

CT

0.446

0.1881

TT

0.019

0.6840

CC

0.245

0.9740

ADIPOQ

       

rs1501299- rs2241766

1

0.168

GG

0.301

0.9740

0.047

1047

TG

0.418

0.9740

TT

0.281

0.9740

TGFB1

       

rs4803455- rs1800470

0.88

0.628

CG

0.573

0.8766

0.033

1363

AA

0.326

0.8766

AG

0.025

0.8766

CA

0.076

0.9740

rs1800470-rs1800469

1

0.936

AG

0.391

0.8766

0.061

875

GA

0.594

0.8766

AA

0.012

0.9740

rs4803455-rs1800470-rs1800469

0.883

0.648

AAG

0.322

0.8766

0.097

638

CGA

0.573

0.8766

CAG

0.069

0.9740

AGA

0.021

0.9740

Five haplotype windows (HWs) include rs662-rs705379, rs1501299-rs2241766, rs4803455-rs1800470, rs1800470-rs1800469, and rs4803455-rs1800470-rs1800469. Post-RT duration and number of cardiovascular risk factors were adjusted using linear regression in all analyses. Multiple testing was corrected by false discovery rate. Statistical power (1-β) was calculated using the model with smallest observed P value. SS0.8 was the sample size to achieve a statistical power of 0.8 in the corresponding analysis. Hap, haplotype; Freq, frequency; P cor , Corrected P value.

Discussion

Carotid atherosclerosis is a common complication in post-RT NPC patients. However, the mechanisms of radiation-induced carotid atherosclerosis are still unclear and no previous study has reported the association between genetic polymorphisms and radiation-induced carotid atherosclerosis. The present study comprehensively investigated the association between 13 SNPs in anti-atherosclerotic genes and radiation-induced carotid atherosclerosis. Results showed that SNPs in PON1 tended to be genetically associated with carotid plaque score in post-RT NPC patients.

PON1 is one of the important enzymes for hydrolyzing LDL oxidation, playing a pivotal role against carotid atherosclerosis. The SNP rs662 (T > C) locating in the coding region of PON1 gene replaces glutamine (Q) by arginine (R) at codon 192 (Q192R). This variation affects the activities of PON1 in the hydrolysis of different substrates. The 192Q allozyme has higher hydrolytic activity toward diazoxon, soman and sarin, while the 192R allozyme is more efficient for hydrolyzing paraoxon and fenitroxon [35,36]. Another important variation, rs705379, is located at position −107 of the promoter region (−107 T/C), which contributes to a decrease in the PON1 expression level and PON1 circulating concentration [37].

In the present study, significant observed P values were found in the association analyses between carotid plaque score and rs662 as well as rs705379 in additive and dominant models (rs662, P = 0.0054 and 0.0014 respectively; rs705379, P = 0.0077 and 0.0086 respectively). The significant association failed to survive in the correction for multiple testing by FDR, but it was close to be significant (P cor  = 0.0528 and 0.0842 respectively). In the association analyses with rs662 and rs705379, the statistical power was 0.524 and 0.302 respectively. To achieve a statistical power of 0.8, at least 194 and 283 patients would be needed respectively. Therefore, small sample size in the present study (n = 128) may account for the non-significant findings. Future studies with larger sample sizes are needed for investigating the association. Nevertheless, the two SNPs had a cumulative effect on carotid plaque score. Patients carrying T allele in rs662 (QR + QQ, n = 64) had 1.76 ± 1.60 of carotid plaque score, whilst those with CC genotype in rs705379 (n = 44) had 1.79 ± 1.82 of carotid plaque score. In patients carrying both T allele in rs662 and CC genotype in rs705379 (n = 38), the plaque score was 1.94 ± 1.89. TC haplotype in rs662-rs705379 showed significant association with the plaque score after the correction for multiple testing (P cor  = 0.0158). Thus, rs662 and rs70539 in combination were more powerful to detect the association with carotid plaque score in the present study. TC in rs662-rs705379 would be the risk haplotype for carotid plaque score in post-RT NPC patients.

D’ and r2 of the two SNPs were 0.871 and 0.294 respectively. The high D’ indicated that the two SNPs were in LD and were co-inherited most of the time. However, the different frequencies of alleles in the two SNPs (minor allele frequency = 0.3086 and 0.4648 respectively) resulted in the low r2. Therefore, the two SNPs cannot predict for each other.

In contrast to previous studies in which the R variant of the Q192R polymorphism (C allele in rs662) was a risk factor for spontaneous atherosclerosis diseases [21,38], the present study found that the R variant would be protective for radiation-induced carotid atherosclerosis. Patients carrying RR had lower plaque score as compared to those with QR and QQ genotypes (RR vs QR + QQ: 1.07 ± 0.97 vs 1.76 ± 1.60). In an in vitro model, Aviram et al. documented that RR and QQ allozymes serve anti-oxidant activities in different stages based on different substrates [39]. The various hydrolytic activities of R and Q allozymes in PON1 for different substrates may account for the conflicting results between the present and previous studies. The oxidative condition in the irradiated cases may be different from that in those without radiation treatment. PON1 may protect LDL from oxidation by a certain activity based on the different substrates in the irradiated cases and the non-irradiated ones. Thus, RR of Q192R polymorphism would be protective against radiation-induced carotid atherosclerosis, although it may be the risk of spontaneous atherosclerosis diseases.

Limitations

The present study was a cross-sectional investigation with only 128 post-RT NPC patients and without a non-irradiated control group. The study design and small sample size limited the statistical power in association analyses. Thus, the potential association between some SNPs and carotid plaque score in post-RT NPC patients, and the potential interaction between the TC haplotype and irradiation, may not be fully investigated. In addition, the present study did not investigate the PON1 concentration and activity due to limited resources. Whether the TC haplotype decreases the concentration and activity of PON1 and consequently promotes the plaque score in post-RT NPC patients remains to be confirmed in future studies. Given that this study was an exploratory investigation, and the sample size and study design were limited, future investigations, especially prospective studies, are suggested to investigate the role of PON1 in the development of radiation-induced carotid atherosclerosis and the effectiveness of using the TC haplotype in the prevention of radiation-induced carotid atherosclerosis.

Conclusion

TC haplotype in rs662-rs705379 of PON1 is likely to be a genetic risk factor of carotid plaque score. The present study provides preliminary finding of the association between genetic polymorphisms with the radiation-induced carotid atherosclerosis in post-RT NPC patients, which facilitates the understanding of genetic markers for the selection of NPC patients with high risk of carotid atherosclerosis so as to conduct appropriate examinations for early diagnosis and prompt treatment for carotid atherosclerosis in post-RT NPC patients.

Declarations

Acknowledgements

We thank the staff in the Department of Clinical Oncology of Queen Mary Hospital for their assistance in the study. This study was supported by a research studentship from the Hong Kong Polytechnic University (RU2R).

Authors’ Affiliations

(1)
Department of Health Technology and Informatics, The Hong Kong Polytechnic University
(2)
Department of Clinical Oncology, The University of Hong Kong
(3)
Current address: Medical Research Center, Changsha Central Hospital

References

  1. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev. 2006;15:1765–77.View ArticleGoogle Scholar
  2. Lu H, Yao M. The current status of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma. Cancer Treat Rev. 2008;34:27–36.View ArticlePubMedGoogle Scholar
  3. Muzaffar K, Collins SL, Labropoulos N, Baker WH. A prospective study of the effects of irradiation on the carotid artery. Laryngoscope. 2000;110:1811–4.View ArticlePubMedGoogle Scholar
  4. Lam WW, Leung SF, So NM, Wong KS, Liu KH, Ku PK, et al. Incidence of carotid stenosis in nasopharyngeal carcinoma patients after radiotherapy. Cancer. 2001;92:2357–63.View ArticlePubMedGoogle Scholar
  5. Lam WW, Yuen HY, Wong KS, Leung SF, Liu KH, Metreweli C. Clinically underdetected asymptomatic and symptomatic carotid stenosis as a late complication of radiotherapy in Chinese nasopharyngeal carcinoma patients. Head Neck. 2001;23:780–4.View ArticlePubMedGoogle Scholar
  6. Li CS, Schminke U, Tan TY. Extracranial carotid artery disease in nasopharyngeal carcinoma patients with post-irradiation ischemic stroke. Clin Neurol Neurosurg. 2010;112:682–6.View ArticlePubMedGoogle Scholar
  7. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002;33:337–49.View ArticlePubMedGoogle Scholar
  8. He SQ, Zhang YH, Venugopal SK, Dicus CW, Perez RV, Ramsamooj R, et al. Delivery of antioxidative enzyme genes protects against ischemia/reperfusion-induced liver injury in mice. Liver Transpl. 2006;12:1869–79.View ArticlePubMedGoogle Scholar
  9. Aviram M, Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med. 2004;37:1304–16.View ArticlePubMedGoogle Scholar
  10. Li AC, Binder CJ, Gutierrez A, Brown KK, Plotkin CR, Pattison JW, et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest. 2004;114:1564–76.View ArticlePubMed CentralPubMedGoogle Scholar
  11. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun. 2004;323:630–5.View ArticlePubMedGoogle Scholar
  12. Wakkach A, Cottrez F, Groux H. Can interleukin-10 be used as a true immunoregulatory cytokine? Eur Cytokine Netw. 2000;11:153–60.PubMedGoogle Scholar
  13. Wahl SM, Wen J, Moutsopoulos N. TGF-beta: a mobile purveyor of immune privilege. Immunol Rev. 2006;213:213–27.View ArticlePubMedGoogle Scholar
  14. Napoli C, Ignarro LJ. Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis. J Clin Pathol. 2007;60:341–4.View ArticlePubMed CentralPubMedGoogle Scholar
  15. Kakko S, Paivansalo M, Koistinen P, Kesaniemi YA, Kinnula VL, Savolainen MJ. The signal sequence polymorphism of the MnSOD gene is associated with the degree of carotid atherosclerosis. Atherosclerosis. 2003;168:147–52.View ArticlePubMedGoogle Scholar
  16. Casas JP, Bautista LE, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase genotype and ischemic heart disease - Meta-analysis of 26 studies involving 23028 subjects. Circulation. 2004;109:1359–65.View ArticlePubMedGoogle Scholar
  17. Fujimoto H, Taguchi JI, Imai Y, Ayabe S, Hashimoto H, Kobayashi H, et al. Manganese superoxide dismutase polymorphism affects the oxidized low-density lipoprotein-induced apoptosis of macrophages and coronary artery disease. Eur Heart J. 2008;29:1267–74.View ArticlePubMedGoogle Scholar
  18. Naganuma T, Nakayama T, Sato N, Fu Z, Soma M, Aoi N, et al. Association of extracellular superoxide dismutase gene with cerebral infarction in women: a haplotype-based case–control study. Hereditas. 2008;145:283–92.View ArticlePubMedGoogle Scholar
  19. Deng HB, Jiang CQ, Tomlinson B, Liu B, Lin JM, Wong KS, et al. A polymorphism in transforming growth factor-beta1 is associated with carotid plaques and increased carotid intima-media thickness in older Chinese men: the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort. Atherosclerosis. 2010;214:391–6.View ArticlePubMedGoogle Scholar
  20. Dutkiewicz G, Domanski L, Binczak-Kuleta A, Pawlik A, Safranow K, Ciechanowicz A, et al. The association of -262C/T polymorphism in the catalase gene and delayed graft function of kidney allografts. Nephrology (Carlton). 2010;15:587–91.View ArticleGoogle Scholar
  21. Wang MS, Lang XL, Zou LJ, Huang SD, Xu ZY. Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: A meta-analysis based on 88 case–control studies. Atherosclerosis. 2011;214:377–85.View ArticlePubMedGoogle Scholar
  22. Morris DR, Moxon JV, Biros E, Krishna SM, Golledge J. Meta-Analysis of the Association between Transforming Growth Factor-Beta Polymorphisms and Complications of Coronary Heart Disease. Plos One. 2012;7:e37878.View ArticlePubMed CentralPubMedGoogle Scholar
  23. Zhang H, Mo XB, Hao YC, Gu DF. Association between polymorphisms in the adiponectin gene and cardiovascular disease: a meta-analysis. BMC Med Genet. 2012;13:40.View ArticlePubMed CentralPubMedGoogle Scholar
  24. Wu ZJ, Lou YQ, Jin W, Liu Y, Lu L, Lu GP. The C161T polymorphism in the peroxisome proliferator-activated receptor gamma gene (PPAR gamma) is associated with risk of coronary artery disease: a meta-analysis. Mol Biol Rep. 2013;40:3101–12.View ArticlePubMedGoogle Scholar
  25. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.View ArticlePubMedGoogle Scholar
  26. Carretero OA, Oparil S. Essential hypertension Part I: definition and etiology. Circulation. 2000;101:329–35.View ArticlePubMedGoogle Scholar
  27. Ford ES, Li CY, Pearson WS, Zhao GX, Mokdad AH. Trends in hypercholesterolemia, treatment and control among United States adults. Int J Cardiol. 2010;140:226–35.View ArticlePubMedGoogle Scholar
  28. Chang YJ, Chang TC, Lee TH, Ryu SJ. Predictors of carotid artery stenosis after radiotherapy for head and neck cancers. J Vasc Surg. 2009;50:280–5.View ArticlePubMedGoogle Scholar
  29. Jiang B, Yap MK, Leung KH, Ng PW, Fung WY, Lam WW, et al. PAX6 haplotypes are associated with high myopia in Han chinese. Plos One. 2011;6:e19587.View ArticlePubMed CentralPubMedGoogle Scholar
  30. Mak JY, Yap MK, Fung WY, Ng PW, Yip SP. Association of IGF1 gene haplotypes with high myopia in Chinese adults. Arch Ophthalmol. 2012;130:209–16.View ArticlePubMedGoogle Scholar
  31. Yiu WC, Yap MK, Fung WY, Ng PW, Yip SP. Genetic susceptibility to refractive error: association of vasoactive intestinal peptide receptor 2 (VIPR2) with high myopia in Chinese. Plos One. 2013;8:e61805.View ArticlePubMed CentralPubMedGoogle Scholar
  32. Matthews KA, Kuller LH, Sutton-Tyrrell K, Chang YF. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke. 2001;32:1104–11.View ArticlePubMedGoogle Scholar
  33. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–75.View ArticlePubMed CentralPubMedGoogle Scholar
  34. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet. 2005;76:887–93.View ArticlePubMed CentralPubMedGoogle Scholar
  35. Richter RJ, Jampsa RL, Jarvik GP, Costa LG, Furlong CE. Determination of paraoxonase 1 status and genotypes at specific polymorphic sites. Curr Protoc toxicol. 2004;UNIT 4:12.Google Scholar
  36. Ginsberg G, Neafsey P, Hattis D, Guyton KZ, Johns DO, Sonawane B. Genetic Polymorphism in Paraoxonase 1 (Pon1): Population Distribution of Pon1 Activity. J Toxicol Environ Health B Crit Rev. 2009;12:473–507.View ArticlePubMedGoogle Scholar
  37. Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE. Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet. 2001;68:1428–36.View ArticlePubMed CentralPubMedGoogle Scholar
  38. Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J. Four paraoxonase gene polymorphisms in 11,212 cases of coronary heart disease and 12,786 controls: meta-analysis of 43 studies. Lancet. 2004;363:689–95.View ArticlePubMedGoogle Scholar
  39. Aviram M, Billecke S, Sorenson R, Bisgaier C, Newton R, Rosenblat M, et al. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vasc Biol. 1998;18:1617–24.View ArticlePubMedGoogle Scholar

Copyright

© Yuan et al.; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement